AD-2284

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-2284, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284 [Phase 1]